Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.
Vaccination-induced bilateral optic neuritis: rare but existing.
Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis.
Axonal selection and myelin sheath generation in the central nervous system.
Reporting treatment outcomes in observational data: A fine balance.
Central nervous system inflammation across the age span.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Visual issues in multiple sclerosis.
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
The NLR family member, NLRX1, mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglial-induced inflammation.
A spectrum of inflammation and demyelinization in acute disseminated encephalomyelitis (ADEM) of children.
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Illness perception, treatment beliefs, self-esteem, and self-efficacy as correlates of self-management in multiple sclerosis.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
[Analysis of clinical pathway in changing and disabling neurological diseases.]
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
Hypersensitivity Responses in the Central Nervous System.
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
Pages
« first
‹ previous
…
549
550
551
552
553
554
555
556
557
…
next ›
last »